Ecraid introduces new COO Nils Visser
Nils has over 10 years’ experience in Clinical Trial execution and joined University Medical Center Utrecht (UMCU) in 2020 as Manager of Clinic Operations in the COVID-19 trial unit. He progressively took on new roles and challenges within the UMCU’s European Project Group, including leading role in the Group’s transition to Ecraid. Prior to this, Nils was Operations Director at Semiotic Labs, a start-up where he managed all operational aspects from supply chain strategy to project management and quality.
Nils brings with him more than 35 years of proven industry and professional experience in international environments. His strong track record in project management, operational excellence and change management will contribute to our mission to tackle infectious diseases by joining forces and creating the highest quality clinical evidence. Nils says:
I am honoured for the opportunity and look forward to help execute on Ecraid’s mission to develop innovative clinical trial concepts that will advance the fight against infectious diseases. By working closely with industry and academia, we have high chances to respond faster and more effectively to clinical outbreaks and advance our fight against infectious diseases.
In his new role, Nils will be a part of Ecraid’s management board and responsible for business planning and control, operational execution, quality and risk management, IT strategy development, and business support functions along with sustaining operational relations. Ecraid CEO Marc Bonten says: "Nils has made invaluable contributions to our organisation, and I have no doubt that as COO, he will help implement strategic vision and values of Ecraid Foundation, and drive growth."
Please join us in congratulating Nils on his new leadership role at Ecraid Foundation.
The European Clinical Research Alliance on Infectious Diseases (Ecraid) is a not-for profit foundation that advances clinical research in the field of infectious diseases by establishing a long-term, financially self-sustainable, clinical research network in Europe. Headquartered in Utrecht, the Netherlands, Ecraid is the first network of its kind in Europe to offer a single point of access to a pan-European clinical research network for infectious diseases and spans 1,100 clinical sites and 900 laboratories across 42 countries. For more information, please visit www.ecraid.eu.
For more information, please contact:
Ecraid Press Office
Daniele Pazzola, Communications Manager
Tel: +32 476 74 28 68